COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,899 Articles (22,568 medRxiv, 8,331 bioRxiv)

Most recent first Previous |  Page 1483: Articles 14821-14830  | Next

Vaccination against COVID-19 and society return to normality in England: a modelling study of impacts of different types of naturally acquired and vaccine induced immunity
Song, F., Bachmann, M. O.
10.1101/2021.05.18.21257314 — Posted: 2021-05-18
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
Muena, N. A., Garcia-Salum, T., Pardo-Roa, C., Serrano, E. F., Levican, J., Avendano, M. J., Almonacid, L. I., Valenzuela, G., Poblete, E., Strohmeier, S., Salinas, E., Haslwanter, D., Dieterle, M. E., Jangra, R. K., Chandran, K., Gonzalez, C., Riquelme, A., Krammer, F., Tischler, N. D., Medina, R. A.
10.1101/2021.05.17.21257197 — Posted: 2021-05-18
Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy
Theiler, R. N., Wick, M., Weaver, A., Mehta, R., Virk, A., Swift, M.
10.1101/2021.05.17.21257337 — Posted: 2021-05-18
Public attitudes to COVID-19 vaccines: A qualitative study
Williams, S. N., Dienes, K. A.
10.1101/2021.05.17.21257092 — Posted: 2021-05-18
Will there be a third COVID-19 wave? A SVEIRD model based study of Indian situation.
Kannan, D., R, G., Banerjee, R., Bhattacharjee, S., Varadwaj, P. K.
10.1101/2021.05.16.21257300 — Posted: 2021-05-18
Platelet expression and reactivity after BNT162b2 vaccine administration
Klug, M. E., Lazareva, O., Kirmes, K., Rosenbaum, M., Lukas, M., Weidlich, S., Spinner, C. D., von Scheidt, M., Gosetti, R., Baumbach, J., Ruland, J., Condorelli, G., Laugwitz, K.-L., List, M., Bernlochner, I., Bongiovanni, D.
10.1101/2021.05.18.21257324 — Posted: 2021-05-18 Discussion: Onsite
Evaluation of High Flow Local Extraction on control of the aerosol plume in an operating theatre
Marriott, L., Harper, M., Zhou, T., Sun, C.
10.1101/2021.05.16.21257155 — Posted: 2021-05-18
SARS-CoV-2 Vaccine-Induced Antibody Response and Reinfection in Persons with Past Natural Infection
Chauhan, N., Chahar, A. S., Singh, P., Bhavesh, N. S., Tandon, R., Chaturvedi, R.
10.1101/2021.05.18.21257259 — Posted: 2021-05-18
Phylogenomics and population genomics of SARS-CoV-2 in Mexico reveals variants of interest (VOI) and a mutation in the Nucleocapsid protein associated with symptomatic versus asymptomatic carriers
Barona-Gomez, F., Delaye, L., Diaz-Valenzuela, E., Plisson, F., Cruz-Perez, A., Diaz-Sanchez, M., Garcia-Sepulveda, C. A., Sanchez-Flores, A., Perez-Abreu, R., Valencia-Valdespino, F. J., Vega-Magana, A. N., Munoz-Valle, J. F., Garcia-Gonzalez, O. P., Bernal-Silva, S., Comas-Garcia, A., Cibrian Jaramillo, A.
10.1101/2021.05.18.21256128 — Posted: 2021-05-18
Implications Derived from S-Protein Variants of SARS-CoV-2 from Six Continents
Hassan, S. S., Lundstrom, K., Pal Choudhury, P., Palu, G., Uhal, B., Kandimalla, R., Seyran, M., Lal, A., Sherchan, S. P., Azad, G. K., Aljabali, A. A. A., Brufsky, A., Serrano-Aroca, A., Adadi, P., Abd El-Aziz, T. M., Redwan, E. M., Takayama, K., Barh, D., Rezaei, N., Tambuwala, M., Uversky, V. N.
10.1101/2021.05.18.444675 — Posted: 2021-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).